Clinical Trials Directory

Trials / Completed

CompletedNCT05537675

Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction

Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction in Refractory Meningiomas Treated by SSTR-targeted Peptide Receptor Radionuclide Therapy

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Tumor dosimetry with somatostatin receptor-targeted peptide receptor radionuclide therapy (SSTR-targeted PRRT) by 177Lutetium-DOTATATE might contribute to improve follow-up and treatment response of refractory meningiomas. This study aims to evaluate Standard Uptake Value mean (SUVmean) as a tumoral absorbed dose predictive predictive factor and propose semi-automated segmentation method to determine metabolic tumor volume with pretherapeutic 68-Gallium-DOTATOC PET.

Conditions

Interventions

TypeNameDescription
OTHERTo evaluate the SUVmean (Standard Uptake Value) as a predictive factor of the tumor absorbed dose compared to the SUVmaxMeasure SUVmean (Standard Uptake Value) and SUVmax on PET exams

Timeline

Start date
2022-10-01
Primary completion
2022-11-06
Completion
2022-11-30
First posted
2022-09-13
Last updated
2023-11-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05537675. Inclusion in this directory is not an endorsement.

Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction (NCT05537675) · Clinical Trials Directory